- About Us
- Services & Solutions
- WuXi XDC – Bioconjugation
- News & Media
Offering End-to-End Solutions
WuXi Biologics is a leading global open-access biologics technology platform company with more than 9,400 employees from various backgrounds and nationalities supporting our customers and patients around the world. We believe that Diversity, Equity and Inclusion is critical to the sustainable growth and innovation of our business.
As an equal opportunity employer, WuXi Biologics recruits employees based on their professional and academic achievements regardless of religion, disability, age, race, color, sex, gender identity, sexual orientation, or marital status.
We are committed to gender parity. This includes ensuring that women earn equal pay for equal work and are encouraged to pursue both professional development and personal growth while employed by WuXi Biologics. We are also committed to ensuring that our diversity is reflected in our leadership and management teams – including our Board of Directors.
We have partnered with nonprofits that focus on the rights of people with disabilities. We offer employees with disabilities equal compensation and opportunities for promotion and professional development.
WuXi Biologics recently established an internal team to better incorporate the principles of Diversity, Equity and Inclusion into our workplace. Earlier this year, the group organized a series of online trainings for nearly 300 employees on the topics of unconscious bias, inclusive female leadership, and recruitment of diverse talent.
PUTTING PEOPLE FIRST
Our commitment to Diversity, Equality and Inclusion means not only reflecting these principles in our hiring practices, but also creating a workplace environment that allows all employees to thrive. We offer our employees Women’s Day gifts, inclusive healthcare options, and private nursing rooms across our sites.
We also fund various programs to allow employees to connect outside of work and promote a healthy work-life balance, including dance, sports, photography, E-sports, and music clubs. The employee associations at our site in Wuxi City, China have organized nearly 200 activities with over 4,000 participants.
WuXi Biologics’ Volunteer Association has consistently grown since its establishment in December 2020. Nearly 450 employees are members of the group, 70% of which are women. The Volunteer Association has hosted 4 employee trainings and coordinated 8 volunteer opportunities contributing over 1,600 volunteer hours. In the future, WuXi Biologics’ Volunteer Association will also continue to provide regular trainings for volunteers so our employees can give back to their communities through a range of corporate social responsibility initiatives.
With a focus on professional development, we have established several internal learning and training courses for our employees on the topics of anti-corruption, information security, and workplace safety. For example, we launched a series of lectures called “Master Class,” which has helped over 10,000 employees at various levels of the company improve their knowledge of WuXi Biologics’ capabilities.
Our PROUD Culture – which emphasizes Passion, Reward, Ownership, Unity and Determination – values individual long-term development. With this in mind, we offer employees support while they pursue graduate education and offer the ability to transfer between departments and sites in order to retain employees while they grow professionally and personally.
The long-term development of our female employees is a focus of our Diversity, Equity and Inclusion efforts. With this in mind, we have implemented trainings and seminars in partnership with sHero – a nonprofit focused on female leadership – to promote creativity, multi-cultural expression and career development among our employees. These programs will extend to new sites as our company continues to grow.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company’s history and achievements demonstrate its commitment to providing a truly ONE-stop service offering and strong value proposition to its global clients.
The company is currently conducting on behalf of its clients and partners (as of June 30, 2021) a total of 408 integrated projects, including 212 in pre-clinical development stage, 160 in early-phase (phase I and II) clinical development, 32 in late-phase (phase III) development and 4 in commercial manufacturing. With a total estimated capacity of exceeding 430,000 liters for biopharmaceutical production planned after 2024 in China, Ireland, the U.S., Germany, and Singapore, WuXi Biologics will provide its biomanufacturing partners with a robust and premier-quality global supply chain network.
WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of its ethos and business strategy and aims to become a global ESG leader in biologics manufacturing. We use next-generation clean biomanufacturing technologies and utilize cleaner energy sources. We have also established an ESG committee led by the CEO to increase efficiency while advancing commitment to sustainability. For more information about WuXi Biologics, please visit: www.wuxibiologics.com.